{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:19:16Z","timestamp":1776129556904,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jpba.2013.12.027","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T13:00:22Z","timestamp":1388754022000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development and application to clinical practice of a validated HPLC method for the analysis of \u03b2-glucocerebrosidase in Gaucher disease"],"prefix":"10.1016","volume":"91","author":[{"given":"E. Gras","family":"Colomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A. Mart\u00ednez","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Gonz\u00e1lez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Climente","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Le\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Fern\u00e1ndez","family":"Zarzoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.V.","family":"Jim\u00e9nez-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.12.027_bib0005","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2013 macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0010","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpba.2013.12.027_bib0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2","volume":"282","author":"Boot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0020","doi-asserted-by":"crossref","first-page":"30889","DOI":"10.1074\/jbc.M700832200","article-title":"Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase","volume":"282","author":"Hayashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/clinchem\/28.4.569","article-title":"Beta-glucosidase assays in the diagnosis of Gaucher's disease","volume":"28","author":"Daniels","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0030","first-page":"747","article-title":"The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes","volume":"76","author":"Beutler","year":"1970","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0035","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood.V89.9.3412","article-title":"Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity","volume":"89","author":"Lorincz","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2013.12.027_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ab.2008.07.024","article-title":"A sensitive and reproducible fluorescent-based HPLC assay to measure the activity of acid as well as neutral beta-glucocerebrosidases","volume":"383","author":"Hayashi","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcmd.2007.02.008","article-title":"A pharmacokinetic analysis of a novel enzyme replacement therapy with gene-activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease","volume":"39","author":"Zimran","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jpba.2013.12.027_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2\u20135 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher's disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2013.12.027_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcmd.2010.07.008","article-title":"Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease","volume":"46","author":"Elstein","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jpba.2013.12.027_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jpba.2013.12.027_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0075","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-02-268649","article-title":"Phase 1\/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience","volume":"115","author":"Zimran","year":"2010","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.jpba.2013.12.027_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0025-7753(11)70019-7","article-title":"Guidelines for type 1 Gaucher's disease","volume":"137","author":"Giraldo","year":"2011","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.jpba.2013.12.027_bib0085","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1002\/elps.200500304","article-title":"Multivariate optimization approach for chiral resolution of drugs using human serum albumin in affinity electrokinetic chromatography-partial filling technique","volume":"26","author":"Martinez-Gomez","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2013.12.027_bib0090","series-title":"Principles of Therapeutic Drug Monitoring","article-title":"Applied pharmacokinetics","author":"Evans","year":"1992"},{"issue":"Suppl.","key":"10.1016\/j.jpba.2013.12.027_bib0095","first-page":"2","article-title":"Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects","volume":"1","author":"Marquet","year":"1999","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.jpba.2013.12.027_bib0100","first-page":"28526","article-title":"Guidance for industry on bioanalytical method validation. US Department of Health and Human Services","volume":"66","author":"FDA","year":"2001","journal-title":"Fed. Reg."},{"key":"10.1016\/j.jpba.2013.12.027_bib0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(80)90168-0","article-title":"A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase","volume":"106","author":"Daniels","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.12.027_bib0110","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1016\/S0021-9258(19)83905-4","article-title":"Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes","volume":"261","author":"Grabowski","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0115","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"Beta-glucosidase 2 (GBA2) activity and imino sugar pharmacology","volume":"288","author":"Ridley","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0120","doi-asserted-by":"crossref","first-page":"11261","DOI":"10.1074\/jbc.272.17.11261","article-title":"Purification and characterization of a microsomal bile acid beta-glucosidase from human liver","volume":"272","author":"Matern","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2013.12.027_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cccn.2004.01.010","article-title":"Biochemical study on \u03b2-glucosidase in individuals with Gaucher's disease and normal subjects","volume":"343","author":"Michelin","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.12.027_bib0130","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM199212033272304","article-title":"A less costly regimen of alglucerase to treat Gaucher's disease","volume":"327","author":"Figueroa","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2006-03-010801","article-title":"Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher disease","volume":"108","author":"Zimran","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2013.12.027_bib0140","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease","volume":"1","author":"Beutler","year":"2004","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpba.2013.12.027_bib0145","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2013.12.027_bib0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(95)91422-6","article-title":"Treatment regimens in Gaucher's disease","volume":"346","author":"Beutler","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2013.12.027_bib0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/bcmd.1995.0012","article-title":"The clinical course of treated and untreated Gaucher disease. A study of 45 patients","volume":"21","author":"Beutler","year":"1995","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513006122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513006122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T09:49:31Z","timestamp":1647856171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513006122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"alternative-id":["S0731708513006122"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.12.027","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application to clinical practice of a validated HPLC method for the analysis of \u03b2-glucocerebrosidase in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}